Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases

Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients

(2013) Edward A. Levine et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2012) Terence C. Chua et al.   JOURNAL OF CLINICAL ONCOLOGY

Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix

(2011) C. H. Lieu et al.   ANNALS OF ONCOLOGY

Prognostic Significance of Lymph Node Metastases in Patients with High-Grade Appendiceal Cancer

(2011) Hatem El Halabi et al.   ANNALS OF SURGICAL ONCOLOGY

The Role of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy (CRS/HIPEC) in Patients with High-Grade Appendiceal Carcinoma and Extensive Peritoneal Carcinomatosis

(2011) Hatem El Halabi et al.   ANNALS OF SURGICAL ONCOLOGY

Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy

(2010) D. Elias et al.   EJSO

Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin

(2010) Paul H. Sugarbaker et al.   JOURNAL OF SURGICAL ONCOLOGY